It didn't take long for the price to get back to the original capital raising level. Not too much support around for this common stock. From the latest CR the price from $0.035 peaked $0.08 to get back now to $0.035. This price performance has nothing to do with the fact that is a biotech. This is the typical defensive excuse of whom does not know what to say. Now to get serious again, when is the next announcement expected? We need a jolly here.
It didn't take long for the price to get back to the original...
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
